U.S. Healthtech Stock News

Badger Meter, Inc. recently announced a series of executive leadership changes effective January 1, 2026, including elevating long-time CFO Robert A. Wrocklage to Executive Vice President – North America Municipal Utility and promoting Daniel R. Weltzien to Chief Financial Officer and Treasurer, alongside new roles overseeing SaaS, international utility, and corporate finance functions. The reshuffling concentrates experienced insiders in revenue-facing and software-led roles, signaling an...

Some Urban Outfitters, Inc. ( NASDAQ:URBN ) shareholders may be a little concerned to see that the Co-Founder, Richard...

The Morning Bull - US Market Morning Update Monday, Dec, 15 2025 US stock futures are pointing higher this morning, with contracts linked to the S&P 500 up about 0.4 percent. The move comes as the 10 year Treasury yield creeps toward 4.2 percent, its highest level since September. That higher yield means borrowing costs for mortgages, car loans, and company debt remain elevated, after Federal Reserve officials signaled they are in no rush to cut interest rates further. At the same time, weak...

Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...

Quanex Building Products Corporation recently reported fourth-quarter 2025 results showing sales of US$489.85 million and net income of US$19.57 million, a sharp turnaround from a net loss a year earlier. Despite a full-year net loss driven by a large goodwill impairment, the company generated strong cash flow, repaid US$75 million of debt, continued buybacks totaling 5.37% of shares since 2021, and maintained its US$0.08 quarterly dividend while guiding to broadly flat revenue and EBITDA...

In recent days, Trinity Capital Inc. received new Buy and Market Outperform ratings from Lucid Capital Markets and Citizens, following a quarter in which its revenue surpassed expectations and grew materially year over year. Analysts highlighted Trinity’s internally managed structure, diversified lending verticals, and strong dividend coverage as key reasons for their positive outlook on the company’s profitability profile. We’ll now examine how this combination of upbeat analyst coverage...

Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...

Alkami Technology (ALKT) just rolled out Alkami Foundry, a new hub for developers and fintech partners that opens the company’s platform, deepens integrations, and subtly reframes how investors think about its long term growth engine. See our latest analysis for Alkami Technology. That launch lands against a choppy backdrop, with the share price at $22.29 after a 1 month share price return of 8.84% but a much weaker year to date share price return of 39.59%. The 3 year total shareholder...

Earlier this week, ARK Investment Management, led by Cathie Wood, increased its stake in Schrödinger by purchasing an additional 36,600 shares, signaling growing institutional interest in the company. This incremental buying by a high-profile active manager highlights how Schrödinger’s AI-driven drug discovery platform continues to attract attention from long-term oriented investors. We’ll now examine how ARK’s larger position in Schrödinger could influence the company’s investment...

Most readers would already be aware that Privia Health Group's (NASDAQ:PRVA) stock increased significantly by 12% over...

Kinder Morgan (KMI) just paired fresh 2025 to 2026 earnings guidance with a higher 2026 dividend target, signaling confidence in cash flow and a continued commitment to steadily rewarding income focused shareholders. See our latest analysis for Kinder Morgan. The new dividend and earnings outlook lands after a relatively soft patch for the shares, with a year-to-date share price return of minus 4.91 percent, even as the 1-year total shareholder return sits at about 5 percent. A much stronger...

XPO (XPO) has quietly kept grinding higher, with the stock up about 11% over the past month and 10% in the past 3 months, even after a slight dip yesterday. See our latest analysis for XPO. Zooming out, that recent strength caps a solid year to date, with a 12.5% year to date share price return even though the 1 year total shareholder return is still slightly negative. This suggests sentiment and growth expectations are now rebuilding around XPO. If XPO’s momentum has your attention and you...

Insiders who bought US$264.8k worth of Orion S.A. ( NYSE:OEC ) stock in the last year have seen some of their losses...

Investors who take an interest in Aardvark Therapeutics, Inc. ( NASDAQ:AARD ) should definitely note that the CEO...

With a price-to-earnings (or "P/E") ratio of 9.4x Regional Management Corp. ( NYSE:RM ) may be sending very bullish...

One of the best investments we can make is in our own knowledge and skill set. With that in mind, this article will...

Kronos Worldwide, Inc. ( NYSE:KRO ) shareholders should be happy to see the share price up 14% in the last week. But...

We'd be surprised if Cryoport, Inc. ( NASDAQ:CYRX ) shareholders haven't noticed that the Independent Director...

Key Insights United States Lime & Minerals' estimated fair value is US$163 based on 2 Stage Free Cash Flow to Equity...

Many CorVel Corporation ( NASDAQ:CRVL ) insiders ditched their stock over the past year, which may be of interest to...

Marten Transport, Ltd. ( NASDAQ:MRTN ) shareholders should be happy to see the share price up 22% in the last month...

In early December 2025, Pacira BioSciences reported results from a 30-patient randomized pilot study comparing its ioveradeg cryoneurolysis to radiofrequency ablation for chronic low back pain, alongside recent FDA clearance of a new Smart tip designed for deeper lumbar nerve access. The combination of encouraging comparative pain data and an FDA-cleared hardware enhancement highlights Pacira’s efforts to broaden ioveradeg’s role across spine-related pain pathways beyond its current...

Vertex (VERX) is back in focus after expanding its long running partnership with CPA.com, rolling out an AI powered sales tax platform built with Kintsugi that aims to streamline compliance work for accounting firms. See our latest analysis for Vertex. Despite this AI push and Vertex’s upcoming presence at the Digital CPA Conference, the stock’s 1 year total shareholder return is deeply negative while the 3 year total shareholder return remains solidly positive. This suggests longer term...

Axogen, Inc. recently announced that the U.S. FDA has approved its Biologics License Application for AVANCE, an acellular nerve scaffold indicated for treating a range of peripheral nerve discontinuities in adults and pediatric patients aged one month and older. This transition of AVANCE to a full biologic regulatory framework, with commercial rollout of the licensed product expected in early second-quarter 2026 while current supply continues under the tissue framework, could materially...